Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR AI

Date Submitted: Aug 29, 2022
Date Accepted: Dec 20, 2022

The final, peer-reviewed published version of this preprint can be found here:

Predicting Patient Mortality for Earlier Palliative Care Identification in Medicare Advantage Plans: Features of a Machine Learning Model

Bowers A, Drake C, Makarkin AE, Monzyk R, Maity B, Telle A

Predicting Patient Mortality for Earlier Palliative Care Identification in Medicare Advantage Plans: Features of a Machine Learning Model

JMIR AI 2023;2:e42253

DOI: 10.2196/42253

PMID: 38875557

PMCID: 11041411

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Features of a Machine Learning Model Predicting Mortality for Earlier Palliative Care Identification in Medicare Advantage Plans

  • Anne Bowers; 
  • Chelsea Drake; 
  • Alexi E. Makarkin; 
  • Robert Monzyk; 
  • Biswajit Maity; 
  • Andrew Telle

ABSTRACT

Background:

Machine learning (ML) offers greater precision and sensitivity in predicting Medicare patient end of life (EOL) and potential need for palliative services. However, earlier ML research on older community-dwelling Medicare beneficiaries has provided insufficient exploration of key model feature impacts and the role of the social determinants of health.

Objective:

This study describes the development of a binary classification ML model predicting 1-year mortality among Medicare Advantage plan members aged 65+ (N=318,774), and further examines the top features of the predictive model.

Methods:

A light gradient boosted trees model configuration was selected based on 5 fold cross-validation. The model was trained with 80% of cases (n=255,020) using randomized feature generation periods, with 20% (n=63,754) reserved as a holdout for validation. The final algorithm used 907 feature inputs extracted primarily from claims and administrative data capturing patient diagnoses, service utilization, demographics, and census tract-based social determinants index measures.

Results:

The total sample had an actual mortality prevalence of 3.9% in the 2018 outcome period. The final model positively predicted 41.5% of patient expirations among the top 1% of highest risk members (AUC=0.84; 95% CI: 0.83-0.85), versus 22.2% predicted by the model iteration based on age, gender, and select high-risk utilization features alone (AUC=0.73; 95% CI: 0.72-0.75). The most important algorithm features included patient demographics, diagnoses, pharmacy utilization, mean costs, and certain social determinants of health.

Conclusions:

The final ML model better predicts Medicare Advantage members approaching EOL using a variety of routinely-collected data and can support earlier patient identification for palliative care.


 Citation

Please cite as:

Bowers A, Drake C, Makarkin AE, Monzyk R, Maity B, Telle A

Predicting Patient Mortality for Earlier Palliative Care Identification in Medicare Advantage Plans: Features of a Machine Learning Model

JMIR AI 2023;2:e42253

DOI: 10.2196/42253

PMID: 38875557

PMCID: 11041411

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.